EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan

Bradley S Miller iD, Jo Blair iD, Reiko Horikawa iD, Agnès Linglart iD, Kevin C J Yuen iD

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s315172 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Bradley S Miller und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology, University of Minnesota Medical School, MHealth Fairview Masonic Children's Hospital, Minneapolis, MN, USA. Hauptthemen laut MEDLINE: Human Growth Hormone, Dwarfism, Pituitary, Histidine, Mannitol. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human Growth HormoneDwarfism, PituitaryHistidineMannitolPhenolAdultHumansChildUnited StatesGrowth HormoneTreatment OutcomeInsulin-Like Growth Factor I

Stichwörter der Autor:innen

(3–6): growth hormoneadherenceadult growth hormone deficiencylong-acting growth hormonepediatric growth hormone deficiency

Substanzen

somapacitanHuman Growth HormoneGrowth HormoneInsulin-Like Growth Factor IHistidineMannitolPhenol

Autor:innen und Institutionen

  • Division of Pediatric Endocrinology, University of Minnesota Medical School, MHealth Fairview Masonic Children's Hospital, Minneapolis, MN, USA.
  • Department of Paediatric Endocrinology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
  • Division of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo, Japan.
  • Department of Endocrinology and Diabetes for Children, Hospital Bicêtr Paris Saclay, AP-HP, Le Kremlin-Bicêtre, France.
  • Unité 1185, INSERM, Paris, France.
  • Reference Center for Rare Pituitary Disorders, Hospital Bicêtre Paris Saclay, AP-HP, Le Kremlin-Bicêtre, France.

ORCID-Profile: Bradley S Miller, Jo Blair, Reiko Horikawa, Agnès Linglart, Kevin C J Yuen

Zitieren

APA

Miller, B. S., Blair, J., Horikawa, R., Linglart, A., & Yuen, K. C. J. (2024). Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s315172

Vancouver

Miller BS, Blair J, Horikawa R, Linglart A, Yuen KCJ. Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s315172

BibTeX
@article{Miller2024,
  author = {Miller, Bradley S and Blair, Jo and Horikawa, Reiko and Linglart, Agnès and Yuen, Kevin C J},
  title = {Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s315172}
}
Kostenlos starten →